
Dr. Sam Sanders discusses metabolic dysfunction–associated steatotic liver disease and its management.
Dr. Sam Sanders, internist at Bellevue Hospital in NYC, takes us through a case-based review of metabolic dysfunction–associated steatotic liver disease (MASLD), an increasingly common condition. We cover updated terminology, risk stratification using FIB-4 scoring and FibroScans, indications for hepatology referral, and new management strategies to prevent fibrosis progression and cirrhosis. Advertising Inquiries: https://redcircle.com/brands
Explore listener stats, chart rankings, contacts and more on the Run the List podcast page.